PPARG and Parkinson disease: This study aimed to demonstrate the therapeutic potential of honokiol for neural regeneration activity in PD and hemiparkinsonian rats by suppressing PPARγ activation in rat unilateral striatum using 6-hydroxydopamine injection (6-OHDA) [60].